FDA MedWatch Safety AlertsOriginal article
Convenience Kit Correction: Medline Issues Correction for Kits Containing Huons Lidocaine Hydrochloride and Bupivacaine Hydrochloride in Dextrose Injection
RegulatoryLidocaine Hydrochloride and Bupivacaine Hydrochloride in Dextrose InjectionNegative
AI Analysis
Summary
Medline is issuing a correction to convenience kits by removing recalled Lidocaine Hydrochloride and Bupivacaine Hydrochloride in Dextrose Injection components supplied by Huons from affected kits.
Outcome Details
Product correction - removal of recalled components from convenience kits
Importance:2/10
Sentiment:
-0.50
product_recallcorrectionsafetymedical_device
Read the original article
Published by FDA MedWatch Safety Alerts on August 3, 2026 4:00 AM
